Skip to main content
Category

News

TODAY: U.S. Representative Scholten, Michigan State Representative Snyder, Health Care Advocates to Join Protect Our Care Michigan to Discuss Biden Administration’s Efforts to Lower Rx Drug Costs

***MEDIA ADVISORY FOR THURSDAY JULY 20 AT 1 PM EDT***

Thanks to the Inflation Reduction Act, Michiganders Are Saving on Health Care Costs

LANSING, MI – On Thursday, July 20 at 1 PM EDT, U.S. Representative Hillary Scholten, Michigan State Representative Will Snyder, and health care advocates will join Protect Our Care Michigan to discuss the Biden-Harris administration’s next steps in implementing the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. The administration released the final guidance outlining the process for negotiation, and by Sept. 1, the 10 drugs that are selected for the first round of price negotiations will be announced. 

Speakers will also discuss a new fact sheet from Protect Our Care outlining how the Inflation Reduction Act reduces health care costs for Michiganders— with even more savings on the way as the law’s provisions to give Medicare the power to negotiate and cap seniors’ prescription drug costs take effect. The new fact sheet follows new polling that shows the health care measures in the Inflation Reduction Act are the most popular in the entire bill.

This event comes as Republicans and big drug companies are attacking the Inflation Reduction Act in Congress and the courts. Pharmaceutical giants Merck, Bristol Myers Squibb, Astellas Pharma, and Johnson & Johnson-owned Janssen Pharmaceuticals, as well as the industry’s trade association PhRMA, are laser-focused on undermining the Inflation Reduction Act by filing lawsuits to protect their profits and stop the administration from negotiating lower drug prices. Big Pharma’s GOP allies in Congress have already introduced legislation to repeal the Inflation Reduction Act’s prescription drug provisions, which would increase drug costs for millions of seniors.

PRESS CALL

WHO:
U.S. Representative Hillary Scholten (D-MI-03)
Michigan State Representative Will Snyder (D-87th District)
Rick Hainer, a senior citizen from Muskegon
Derrick Collins, Independent Living Team Manager, Grand Rapids-based Disability Advocates

WHAT: Virtual Press Conference

WHERE: Register to join the Zoom event (Registration required)

WHEN: Thursday, July 20, at 1 PM EDT

TODAY: Wisconsin Attorney General Josh Kaul Joins Health Care Leaders to Discuss Lawsuit Challenging Critical ACA Protections

***MEDIA ADVISORY FOR WEDNESDAY, JULY 19 AT 11:00 AM // 12:00 PM EDT***

Braidwood Management v. Becerra Targets Lifesaving Preventive Care for More than 150 Million Americans 

MADISON, WI — On Wednesday, July 19th at 11:00 AM CDT // 12:00 PM EDT, Wisconsin Attorney General Josh Kaul, Vivent Health Interim President and CEO Brandon Hill, Ph.D., and Mona Williams of Planned Parenthood of Wisconsin will join Protect Our Care Wisconsin to discuss U.S. District Judge Reed O’Connor’s devastating decision to strike down a major provision of the Affordable Care Act (ACA) that requires free coverage of lifesaving preventive health care services. 

Judge O’Connor’s decision in Braidwood Management v. Becerra would end the ACA’s guaranteed free access to essential preventive services including lifesaving cancer screenings, and more. In 2020 alone, more than 150 million Americans benefited from these preventive services. 

More than 300 experts, including leading patient and provider groups, legal and public health experts, organized labor, and more have signed onto briefs calling for the Fifth Circuit to protect the Affordable Care Act’s (ACA) no-cost preventive care provision that more than 150 million Americans currently rely on. 

Speakers will highlight what this decision could mean for Wisconsinites’ access to lifesaving health care services, and discuss what is to come as the lawsuit moves through the court system. 

PRESS EVENT

WHO:
Wisconsin Attorney General Josh Kaul
Brandon Hill, Vivent Health Interim President and CEO, Ph.D.
Mona Williams, Planned Parenthood of Wisconsin

WHAT: Press Conference

WHERE: 600 Williamson St. Suite H, Madison, WI (RSVP to [email protected])

WHEN: Wednesday, July 19 at 11:00 AM CDT // 12:00 PM EDT

BREAKING: J&J and Astellas Join Legal Battle to Protect Their Profits and Rip Away Drug Savings for Millions of Seniors

Two More Drug Companies Join Effort to Stop Medicare From Negotiating Lower Drug Prices 

Washington, D.C. – Today, Johnson & Johnson-owned Janssen Pharmaceuticals joined Astellas Pharma, Merck, Bristol Myers Squibb, PhRMA, and Chambers of Commerce in suing to stop Medicare from using its new power to negotiate lower drug prices. The lawsuits baselessly challenge the constitutionality of the Inflation Reduction Act’s Medicare Prescription Drug Negotiation Program, which will lower drug costs for millions of people on Medicare. Nearly one year ago, President Biden and Congressional Democrats achieved a historic victory against drug companies in enacting the Negotiation Program, making prescription drugs more affordable for American patients who pay up to four times more for the same drugs as people in other wealthy countries. 

In response, Protect Our Care Executive Director Brad Woodhouse issued a statement:

“Drug companies’ greed knows no bounds. While Americans are cutting pills and skipping doses, pharmaceutical companies are putting all of their energy into suing the federal government to protect their ability to charge patients outrageous prices to pad their sky-high profits. Big drug companies spent record amounts on lobbying to kill the Inflation Reduction Act, and now they are doing everything in their power to stop the law from delivering lower costs to patients. The American people will suffer if drug companies get their way.”

Protect Our Care Announces “Lower Costs, Better Care” Nationwide Bus Tour

Care Force One to Travel Across 16+ States, Make Over 30 Stops and Cover Nearly 8,000 Miles in Four Weeks Starting July 31

Washington, D.C. — Protect Our Care is announcing its fifth nationwide bus tour: Lower Costs, Better Care. From New Hampshire to California, elected officials, storytellers, and health care advocates will demonstrate how recent victories by President Biden and Democrats in Congress are already “Driving Down Health Care Costs” by thousands of dollars a year — with even more savings on the way. Kicking off on July 31, Care Force One will roll into districts and states for events to educate Americans about how the Inflation Reduction Act and other health care measures will improve care and lower costs for the American people. Over four weeks, Care Force One will travel to more than 16 states, make more than 30 stops, and travel nearly 8,000 miles. 

Protect Our Care’s bus tour kicks off just as Republicans are ramping up their war on health care. After spending more than $100 million to kill the Inflation Reduction Act, Big Pharma and their Republican allies in Congress are hard at work sabotaging this monumental progress in order to put profits over people. Right now, big drug companies are suing in court to try to take away Medicare’s power to negotiate, and Republican lawmakers have introduced legislation to repeal all of the Inflation Reduction Act drug pricing measures. Republican lawmakers are also considering legislation to slash vital health care programs and recently passed a bill to promote junk plans that can discriminate against people with pre-existing conditions. 

The “Lower Costs, Better Care” four-week tour will promote the work of lawmakers who are fighting tirelessly to improve health care and hold Republicans accountable for trying to roll back this progress and hike costs and rip away protections from the American people.

“Care Force One will crisscross the nation this summer to highlight how President Biden and Democrats in Congress have delivered on their promise to drive down health care costs,” said Protect Our Care Executive Director Brad Woodhouse. “We are working to make sure everyone understands how the Inflation Reduction Act could save them on their health care costs. This legislation touches nearly every household in America, whether you’re a senior or individual with a disability struggling to afford prescription drugs, a family purchasing coverage on your own, or a taxpayer who is sick and tired of lining the pockets of Big Pharma. Throughout the tour, people from all backgrounds will share what this bill means to them and their families and why they need their representatives to step up against any effort to roll back this monumental progress.” 

This summer, President Biden and Congressional Democrats are celebrating the one-year anniversary of the Inflation Reduction Act. Between lowering premium costs by 151 percent on average, capping insulin costs, and stopping Big Pharma’s egregious price hikes, the new legislation is already working for the American people. Soon, seniors’ drug costs will be capped at $2,000 annually, and Medicare will finally be able to negotiate lower drug prices — no thanks to Republicans who unanimously voted to maintain the status quo and keep health care costs high. 

The Inflation Reduction Act By the Numbers

  • 13 million Americans are saving on their health insurance premiums keeping over 2 million Americans insured and saving an average of $2,400 per family.
  • 52 million Medicare beneficiaries will no longer face Big Pharma’s outrageous price hikes that outpace inflation.
  • $35 insulin copays per prescription for Medicare beneficiaries
  • 19 million people with Medicare will save an average of $400 thanks to the Inflation Reduction Act’s $2,000 annual cost caps 
  • 80 of the most expensive prescription drugs will have lower prices because of Medicare negotiations by 2030.

Protect Our Care’s Care Force One will make stops in:
Manchester, New Hampshire on Monday, July 31, 2023
Keene, New Hampshire on Monday, July 31, 2023
Syracuse, New York on Tuesday, August 1, 2023
Kingston, New York on Tuesday, August 1, 2023
Valhalla, New York on Wednesday, August 2, 2023
New York City, New York on Wednesday, August 2, 2023
Scranton, Pennsylvania on Thursday, August 3, 2023
Philadelphia, Pennsylvania on Thursday, August 3, 2023
Connellsville, Pennsylvania on Friday, August 4, 2023
Youngston, Ohio on Monday, August 7, 2023
Toledo, Ohio on Tuesday, August 8, 2023
Lansing, Michigan on Tuesday, August 8, 2023
Eau Claire/La Crosse, Wisconsin on Wednesday, August 9, 2023
Milwaukee/Madison, Wisconsin on Thursday, August 10, 2023
St. Paul, Minnesota on Friday, August 11, 2023
Las Vegas, Nevada on Monday, August 14, 2023
Bakersfield, California on Tuesday, August 15, 2023
Los Angeles, California on Tuesday, August 15, 2023
Orange County, California on Wednesday, August 16, 2023
Palm Springs, California on Wednesday, August 16, 2023
Phoenix, Arizona on Thursday, August 17, 2023
Tucson, Arizona on Thursday, August 17, 2023
Albuquerque, New Mexico on Friday, August 18, 2023
Columbus, Georgia on Monday, August 21, 2023
Atlanta, Georgia on Monday, August 21, 2023
Charlotte, North Carolina on Tuesday, August 22, 2023
Greensboro, North Carolina on Tuesday, August 22, 2023
Raleigh, North Carolina on Wednesday, August 23, 2023
Norfolk, Virginia on Wednesday, August 23, 2023
Richmond, Virginia on Thursday, August 24, 2023
Wilmington, Delaware on Thursday, August 24, 2023 

###

New Navigator Polling: Voters Believe Lowering Prescription Drug and Health Care Costs Most Powerful Part of Inflation Reduction Act

Approaching the One Year Anniversary, Support for the Inflation Reduction Act Remains Strong

New Navigator polling reveals that voters overwhelmingly support the Inflation Reduction Act’s measures to reduce prescription drug and health care costs, with health care provisions being 4 of the 5 most popular items in the landmark bill. An overwhelming 82 percent of voters support capping insulin costs for seniors to $35 per prescription a month, 81 percent support giving Medicare the power to negotiate lower prescription drug prices, 77 percent support capping drug costs at $2,000, and 76 percent support lowering health insurance premiums. Overall, Americans support the Inflation Reduction Act by 43 points (66-23). 

Many of the reforms that have the most public support are also the ones the public is most likely to associate with the Inflation Reduction Act, including Medicare negotiating lower drug prices (81%), capping insulin (79%), and limiting drug costs (73%).

The survey shows that Republicans overwhelmingly support the prescription drug provisions passed by President Biden and Congressional Democrats. Despite Republican lawmakers introducing legislation to repeal these policies, 71% of Republicans support Medicare drug price negotiation and 70% support capping out-of-pocket drug costs for seniors at $2,000 per year.

In response, Protect Our Care Chair Leslie Dach issued the following statement:

“The American people are loud and clear that reducing the cost of health care is their top priority. President Biden and Congressional Democrats are delivering thousands of dollars a year in lower costs for millions of people. Meanwhile, Republicans are continuing their war on health care, promising to overturn the Inflation Reduction Act and supporting Big Pharma’s meritless lawsuits. Once again, Republicans are putting greed above the economic interests of Americans. When will they learn how unpopular their war on health care is with the vast majority of voters?” 

When asked if the Inflation Reduction Act will help families like theirs, a majority of voters (52%) said yes it would. 

This poll not only shows policies that lower health care costs are the most popular, but people also identify the Inflation Reduction Act as a health care bill. 

The GOP War on Health Care Ramps Up as House Republicans Eye Critical Health Care Cuts

New Republican Legislation Includes Severe Cuts to HHS, NIH, and the CDC While Eliminating Funding for the Title X Family Planning Program 

Washington DC — Today, House Republicans released legislation that would put the health and well-being of the American people in jeopardy. The radical bill includes cuts to critical health care agencies, including the Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), and the National Institutes of Health (NIH). The legislation also eliminates funding for the Title X Family Planning Program, which is a lifeline for low-income families across the country for contraception, cancer screenings, and other basic primary and preventive health services. This comes after Republican lawmakers passed legislation to promote junk plans that can discriminate against people with pre-existing conditions. All of these proposals are particularly harmful for communities of color, LGBTQI+, people in rural areas, and other marginalized groups who are more likely to have poorer health and to be living in poverty. In response, Protect Our Care Chair Leslie Dach issued the following statement: 

Republicans are once again showing us who they are and who they serve. They are not interested in protecting the programs that work to advance our nation’s health care system by lowering costs and improving public health. Instead, they are interested in lining the pockets of Big Pharma and the wealthiest individuals and corporations. Ripping away the Title X Family Planning Program is unconscionable at a time when conservatives have made it harder to get abortion care and as America faces a worsening maternal mortality crisis. If Republicans were serious, they would throw out this reckless, ultra-MAGA plan and prioritize legislation to expand access to affordable care, not gutting the programs that people across the nation depend on.”

ROUNDUP: Court Ruling on Affirmative Action Will Have Broad Ranging Effects That Will Harm Health Equity Efforts

On June 29, 2023 the Supreme Court ruled, in a 6-3 decision, that race-conscious admissions, using race as one of many factors that allow for admission into highly selective schools, was unlawful. According to experts this decision will have broad implications not just in higher education admissions but across the country in different industries, including health care. Experts, news coverage, and reactions from key officials and leading organizations have made clear this decision will harm efforts to address the growing racial and ethnic disparities in health care – most notably initiatives to diversify the health workforce, which are proven to reduce bias and improve health outcomes for people of color.

Statements

President of the United States Joe Biden. “[F]or forty-five years, the United States Supreme Court has recognized a college’s freedom to decide… how to build diverse student bodies and to meet their responsibility of opening doors of opportunity for every single American. Today, the Court once again walked away from decades of precedent and make — as the dissent has made clear. The Court has effectively ended affirmative action in college admissions. And I… strongly disagree with the Court’s decision. I’ve always believed that the promise of America is big enough for everyone to succeed and that every generation of Americans [has] benefitted by opening the doors of opportunity… wider to include those who have been left behind. I believe our colleges are stronger when they are racially diverse. We cannot let this decision be the last word. Today, I’m directing the Department of Education to analyze what practices help build a more inclusive and diverse student bodies and what practices hold that back, practices like legacy admissions and other systems that expand privilege instead of opportunity. Colleges and universities should continue their commitment to support, retain, and graduate diverse students and classes.” [6/29/23]

Secretary of the Department of Health and Human Services Xavier Becerra. “The Supreme Court ruling today weakens efforts to make higher education more accessible to members of historically underrepresented groups. People of color have been excluded from attending medical school and joining medical organizations for generations. While progress has been made, there is still a significant deficit in the number of Black and Latino doctors and medical students. We need more health workers, especially those who look like and share the experiences of the people they serve. This builds trust between provider and patient, and helps to improve the overall quality of care. This ruling will make it even more difficult for the nation’s colleges and universities to help create future health experts and workers that reflect the diversity of our great nation. The health and wellbeing of Americans will suffer as a result.” [6/29/23]

President of the American Medical Association Jesse M. Ehrenfeld, M.D., M.P.H. “Today’s decision by the U.S. Supreme Court undermines decades of progress centered on the educational value of diversity, and will reverse gains made in the battle against health inequities. This ruling restricts medical schools from considering race and ethnicity among the multiple factors in admissions policies and will translate into a less diverse physician workforce. Diversity is vital to health care, and this court ruling deals a serious blow to our goal of increasing medical career opportunities for historically marginalized and minoritized people. While our country grows more diverse, historically marginalized communities have been left behind on nearly every health indicator. A physician workforce that reflects the diversity of the nation is key to eliminating racial inequities. There is convincing evidence that racially diverse care teams produce measurably positive health outcomes for patients in historically marginalized populations. The goal is not racially segregated care, but rather a health care workforce in which racial and ethnic representation is a more common aspect of care teams. Eliminating health inequity requires more commitment to, investment in and support for Black, Latinx and Native American and Indigenous communities, and LGBTQ+ people. Yet, today’s ruling undermines policy that was producing positive results and improving the health of our patients, as well as making all physicians better practitioners. This ruling is bad for health care, bad for medicine, and undermines the health of our nation.” [6/29/23]

CEO and Chief Legal Officer of the Association of American Medical Colleges David Skorten M.D. and Frank Trinity JD. “We are deeply disappointed with the U.S. Supreme Court’s decision to dismantle its longstanding precedent in the 2003 case, Grutter v. Bollinger, which had recognized student body diversity as a compelling interest permitting the limited consideration of race in admissions. Today’s decision demonstrates a lack of understanding of the critical benefits of racial and ethnic diversity in educational settings and a failure to recognize the urgent need to address health inequities in our country. The AAMC, informed by decades of research, recognizes the undeniable benefits of diversity for improving the health of people everywhere. We remain committed to enhancing health professional education and practice by emphasizing critical thinking, innovation, effective communication with all patients, and increased access to patient care for an increasingly diverse population.” [6/29/23]

National Hispanic Medical Foundation. “The National Hispanic Medical Association (NHMA) condemns the Supreme Court of the United States decision based on the cases against Harvard College and the University of North Carolina striking down race-based admissions in all colleges and universities across the country. This ruling against affirmative action in higher education rolls back decades of precedent to the 1950’s era of Brown v. Board of Education. Our nation’s future depends on racial equity and diversity in higher education to achieve upward mobility for our families and greater prosperity among our multicultural communities that leads to a thriving economy. We must continue to work together to achieve this goal. We call on government and philanthropy to commit long-term financial investments to community based organizations to develop innovative strategies that will continue to prepare students for the application process that will support diversity in higher education.” [6/29/23]

President of the National Medical Association Garfield Clunie, MD. “The Court has yielded a devastating opinion ruling race-conscious admissions processes unconstitutional. This is a major blow to this nation, including to the health of all Americans, especially those in underserved communities. Diversity in medicine is crucial to the health of this nation. This country should be doing all in its power to be more inclusive in the halls of higher education, not less. Affirmative action policies were designed to address racial bias and inequity, major barriers to ensuring diversity in medicine. These obstacles negatively impact not only the medical profession, but most importantly, the patients that we serve. This ruling is a colossal step backwards that will reverberate for decades to come.” [7/3/23]

President and CEO of the American Association of Colleges of Nursing Deborah Trautman Ph.D. “The American Association of Colleges of Nursing (AACN) joins with the larger higher education community in denouncing this decision, which threatens the creation of more diverse and inclusive learning environments,” said Dr. Deborah Trautman, AACN President and Chief Executive Officer. “AACN reaffirms our commitment to serving as a champion for diversity, equity, and inclusion, while recognizing the importance of a diverse nursing workforce to reducing health disparities, addressing social determinants of health, and improving patient outcomes. We stand with our schools of nursing and will work diligently to identify strategies, to ensure our student populations reflect the broad diversity of our society.” [6/29/23]

General Counsel and Chief Legal Officer of the American College of Obstetricians and Gynecologists Molly Meegan. “Today’s Supreme Court decision is a direct blow to people of color across the United States, who are already at risk of poor health outcomes. We know that racial diversity in health care literally saves lives: research and experience have shown time and time again that disparities in health outcomes decrease when patients are treated by health care professionals who have learned and worked alongside colleagues of different racial and ethnic backgrounds. The best way to ensure diversity in the medical workforce is through holistic considerations of medical school candidates that take into account race, ethnicity, and the lived experiences that each candidate could bring to their career as a physician because of their background. Comprehensive consideration of each medical student candidate as an individual can only benefit the communities for which they will ultimately provide care. More diversity in health care means better-educated physicians; higher quality of care; and healthier people, families, and communities everywhere. Less diversity in health care can mean physicians who may be less equipped to connect with and treat the diverse patient populations they serve and patients with worse health outcomes, both of which cause entire communities to suffer.” [6/29/23]

President of the American College of Physicians Omar T. Atiq, MD, FACP. “The American College of Physicians (ACP) was disappointed to see the Supreme Court decision issued today that rules against the use of affirmative action as a part of a college or university’s comprehensive admissions process. ACP believes that a diverse, equitable, and inclusive physician workforce is crucial to promoting equity and understanding. Diversity in the health care workforce not only benefits underserved patients but improves care for all patients. Evidence has shown diverse populations in educational and medical training settings improves learning outcomes by increasing active thinking and intellectual engagement skills and increases understanding of and empathy for diverse cultures. A diverse physician workforce should include individuals of all races, including Indigenous, Black, Latinx, Asian American, Native Hawaiian, Pacific Islander, and other persons affected by discrimination to better reflect the population for whom we care. Considering race as one of the many determining factors used when considering an individual’s admission to an education program can be an important way to combat the harm that systemic racism and discrimination has in the United States. Affirmative action is one means of helping to promote that diversity. Medical schools and other institutions of higher education should consider a person’s race and ethnicity, alongside other factors that are often considered like socioeconomic status and geographic location, as part of evaluating applicants to counter both past and current discrimination. ACP will continue to advocate for policies that can help to increase diversity and promote equity.” [6/29/23]

Executive Director of the American Public Health Association Georges C. Benjamin, MD. “Without affirmative action, we risk turning the clock back on years of progress that have led to improved outcomes and a more diverse public health and health care workforce. Affirmative action policies and programs have directly resulted in the diversification of the public health and health care workforce, with more practitioners of color working directly in communities that suffer some of the worst health disparities and outcomes. With a more diverse public health and health care workforce, we can address and redress years of systemic racism that has sustained poorer health outcomes for our communities of color. Countless studies confirm that diversity in the health care and public health workforce is critical to addressing health disparities, improving cultural competency, building trust and promoting equity. Public health professionals and physicians that bring different perspectives and experiences to their work and patients can better address socio-cultural factors that influence health and access to care. To not consider an applicant’s full background, especially as underrepresentation of certain minority groups in health professions remains an enduring problem, will ultimately lead to lower minority enrollment and worse overall national health.” [6/29/23]

A Coalition of 12 Civil Rights Groups Including the National Urban League and the NAACP. “The extreme decisions of the Supreme Court to overturn affirmative action in the college admissions process was incredibly disappointing. The conservative-majority court erased decades of momentous progress. The effects of this decision will further perpetuate the deep and structural racism that exists in this country. To claim that affirmative action violates the equal protection clause of the 14th amendment goes to show that there are members of the Supreme Court who are unfamiliar with the amendment’s history and intention. Our nation is stronger because of the unique experiences and talents of all people. Yesterday’s decision serves as a distressing reminder of the uphill battle we continue to face in dismantling systemic racism and the potential implications this decision can have on diversity, equity, and inclusion efforts in the workplace. Despite this Supreme Court ruling, we remain resolute in our commitment to constructing equitable pathways to higher education and the opportunity that comes with it.” [6/29/23]

Joint Statement of the National Council of Asian Pacific Americans. “This decision has implications not only for undergraduate admissions but also for graduate-level admissions, including medical and nursing school. Our communities’ health does best when medical professionals are more likely to understand our experiences. Native Hawaiians and Pacific Islanders continue to be grossly underrepresented in the medical profession, and health equity is further compromised by this decision – particularly in the shadow of the impact of COVID-19 on NHPI communities, which had one of the highest per capita death rates in our nation. The Supreme Court has chosen to ignore the reality of persistent racial discrimination and inequality in our country, and has undermined the efforts of educators and advocates to create more equitable and diverse learning environments. Inclusive education and representation for our communities isn’t just about what’s on the curriculum—it matters who is in the classroom to begin with. For decades, affirmative action has been an essential tool to ensuring that students from all communities have access to higher education. This ruling is a step backwards.” [6/29/23]

Robert Wood Johnson Foundation in a Philanthropic Joint Statement. “The Supreme Court’s decision impedes colleges and universities from selecting their own student bodies and fully addressing systemic racial inequalities that persist. The ruling threatens to return this nation to a time when education and opportunity were reserved for a privileged class. It endangers sixty years of multiracial movements to challenge our nation to live up to the ideals enshrined in our founding documents. In the realm of health, research shows that racially and ethnically representative medical schools produce better-trained physicians and care teams that reflect the communities they serve. Universities and colleges and those organizations supporting them deserve the resources and support to continue their critical mission. Our nation’s future prosperity, vitality, and unity depend upon America becoming a true multiracial democracy—an aspiration that requires racial equity and diversity in higher education. Despite today’s ruling, our foundations will not waver in our commitment to those making the nation’s high ideals a reality for all communities and all people.” [6/29/23]

Headlines

NBC News: The Affirmative Action SCOTUS Ruling Will Have a Negative Impact on Health Equity Efforts. “The Supreme Court’s affirmative action ruling will have far-reaching consequences for Black and Latino students hoping to attend medical school and, in turn, only worsen the health disparities among people of color across the country, experts said. After the high court’s ruling Thursday struck down affirmative action programs at the University of North Carolina and Harvard, many fear that medical and nursing schools and other professional institutions will no longer be able to foster diversity by considering race in their admissions processes. The decision will result in fewer Black physicians and more racial bias in the medical field, said Dr. Uché Blackstock, a physician who is the founder of Advancing Health Equity. Justice Sonia Sotomayor highlighted the ruling’s potential impact on health care… Data and decades of research support Sotomayor’s opinion. Black and Latino people are both more likely to have chronic and life-threatening health conditions and to lack health insurance as a result of systemic racism, according to the Kaiser Family Foundation. However, research has shown that those health outcomes for Black and Latino patients are better when they are treated by doctors who share their race or ethnicity.” [NBC News, 6/29/23]

Bloomberg (Opinion): Supreme Court Ruling on Affirmative Action Will Hurt Health Care. “The Supreme Court’s decision to end affirmative action at universities lands at a time when the US health-care system is already struggling to close egregious racial gaps in health outcomes. Diversifying the health-care workforce has been a critical part of that effort—and something that this ruling could make much harder. Patients, especially Black, Hispanic and Native American patients, now could be worse off. The health-care community has long acknowledged that diversifying the medical workforce is essential for addressing health-care inequities. Study after study shows that when a patient and physician have a shared characteristic, health outcomes improve. Black patients who receive care by Black doctors, for example, receive more time and attention, are more likely to adhere to treatment regimens like taking heart medicine, and are better able to manage complex diseases. Black newborns cared for by Black physicians have better survival rates. Black doctors are also more likely to believe their Black patients’ descriptions of pain and treat them accordingly. Doctors and educators also say that attending medical school with diverse student bodies made them better health-care providers. An analysis of public medical schools in states with affirmative action bans found a 4.8% drop in underrepresented students in the five years after those bans were implemented. Meanwhile, schools without bans had a modest increase in underrepresented students during that time. In ending affirmative action, the Court’s conservative majority just raised a new barrier to addressing inequities in health care. That will take a bad situation and make it even worse.” [Bloomberg (Opinion), 7/3/23]

Stat: Affirmative Action in Medical Schools Has Saved Lives, SCOTUS Ruling Ends That. “Despite decades of research and advocacy, along with millions of dollars committed to eliminate health disparities, generations of Black and brown patients continue to be mistreated and die from the effects of racism in the U.S. This has continued even amid the recent racial reckoning that sounded the alarm for racism as a public health issue. Time after time, studies have shown that class is not protective. Social status is not protective. And in the experience of our fellow physicians, even being a doctor cannot save you from racism in medicine. One solution to address these disparities has been to diversify the medical workforce — a solution that was severely handicapped Thursday when the Supreme Court ruled against affirmative action and race conscious admissions. The latest data on medical school diversity is dismal: 5.7% of all doctors in the U.S. are Black, while 7% are Hispanic, far lower than figures of 13.6% and 18.9% of the general population, respectively. Yet having Black and brown physicians is integral to questioning the status quo in medicine. Put simply, these doctors literally save lives. In fact, a recent study showed that for every 10% increase in the number of Black primary care physicians in a county, there was a 31-day higher life expectancy for Black individuals living there. The Supreme Court has now established a policy that will keep more individuals of color out of the pathway to medicine. By abolishing race-conscious admissions, we are simply quitting while we are behind.” [Stat, 6/30/23]

“Putting People At The Center”: CMS, Health Experts, and Advocates Join Protect Our Care to Discuss Latest Actions to Lower Drug Prices

Watch the Full Event Here. 

Washington, DC — Today, CMS Deputy Administrator and Director Meena Seshamani, AARP Chief Advocacy Officer/Executive Vice President Nancy LeaMond, and Director of the Brookings Schaeffer Initiative on Health Policy Richard Frank joined Protect Our Care and health care advocates for a roundtable discussing how the Inflation Reduction Act is already delivering prescription drug savings to seniors across the nation. The event follows the Biden-Harris administration’s recent guidance on implementing the Inflation Reduction Act’s Drug Price Negotiation Program. 

This fall Medicare will begin to negotiate drug prices for some of the most costly drugs covered under Medicare Part D. Protect Our Care recently released a new report that provides a detailed look at five drugs that may be eligible for the first round of negotiation, underscoring the importance of finally allowing Medicare to negotiate lower drug prices.

Seniors are already saving money as a result of the Inflation Reduction Act’s insulin copay cap and no-cost recommended vaccinations. The law has also reined in Big Pharma’s greed by requiring a rebate from drug companies that hike prices exceeding inflation. Soon, out-of-pocket costs will be capped at $2,000 annually for everyone who relies on Medicare, saving nearly 19 million people with Medicare an average of $400 annually. 

“A theme of everything that we’re doing in Medicare is to put the more than 64 million people who rely on our programs front and center,” said Dr. Meena Seshamani, the Deputy Administrator & Director, the Center for Medicare, Centers for Medicare & Medicaid Services. “It is a very exciting time for us to be able to implement the new drug law. This is about enabling people to access the innovative therapies they need. Through the drug price negotiation process, we are putting people at the center and thinking about the real-world impact of these treatments. Being able to further that conversation will really advance health in our country.”

“It’s very hard to overstate how monumental the Inflation Reduction Act, specifically the Medicare Drug Price Negotiation Program, is for older Americans,” said Nancy LeaMond, Chief Advocacy and Engagement Officer/Executive Vice President at AARP. “This issue is deeply personal for families and impacts their day-to-day lives. We hear every single day how important it is, through our call center, through our meetings across the country, and with our members. The number one reason someone doesn’t fill a prescription is because they can’t afford to. The Inflation Reduction Act was a terrific step forward but we all have a lot to do to help with implementation and to continue to move forward.”

“The Inflation Reduction Act was crafted in a way that paid a tremendous amount of heed to concerns about innovation,” said Dr. Richard Frank, Director of the Brookings Schaeffer Initiative on Health Policy. “Nothing gets negotiated until it’s been out in the market for either nine or 13 years. Think about the types of drugs that are likely to be negotiated, which have been making $400 or $500 million a year for nine or 13 years. The chances of them not having the opportunity to recover their investments at a reasonable rate of return is vanishingly small. The narratives the industry is giving in the courtrooms and on the Hill are different from their narratives on Wall Street.”

“I was diagnosed with inflammatory arthritis and complex auto-immune problems, and now every three months, I spend between $1200 and $1500 out-of-pocket for my prescriptions,” said Sandra Klassen, patient storyteller from Fairfax County, Virginia. “My doctor wants me to try Rinvoq but on Medicare Part D, it will cost me $1300 dollars out-of-pocket a month – which is far too much since I’m retired and on a fixed income. The Medicare Drug Price Negotiation Program provides hope that eventually my expensive prescription costs will be substantially reduced.”

“Millions of seniors are counting on the successful implementation of the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. We know that seniors have struggled with high drug costs for far too long, and the Inflation Reduction Act is bringing much-needed relief,” ​​said Protect Our Care Chair Leslie Dach. “Many of the manufacturers of drugs likely to be eligible for negotiation have exploited the patent system to thwart generic competition and keep their prices high. They’ve made billions in profits while spending tens of millions of dollars on lobbyists and offshoring their profits to avoid U.S. taxes. Now, they’re suing to protect their profits and prevent the negotiation program from going into effect. Fortunately, the Biden administration is committed to helping seniors afford their life-saving medications while ending unchecked drug company greed.”

PRESS CALL: Congresswoman Gwen Moore Joins Protect Our Care Wisconsin to Discuss Biden Administration’s Efforts to Lower Rx Drug Costs Ahead of Upcoming Medicare Drug Negotiations

***MEDIA ADVISORY FOR FRIDAY, JULY 7 @ 11:00 AM CT // 12:00 PM ET***

Thanks to the Inflation Reduction Act, Wisconsinites Are Saving on Health Care Costs

Milwaukee, WI – On Friday, July 7th at 11:00 AM CT, 12:00 PM ET, U.S. Representative Gwen Moore (D-WI-4) will join Protect Our Care Wisconsin to discuss the Biden-Harris administration’s next steps in implementing the Inflation Reduction Act’s Medicare Drug Price Negotiation Program. The administration released the final guidance outlining the process for negotiation, and by September 1, the ten drugs that are selected for the first round of price negotiations will be announced. 

A new report from Protect Our Care highlights the five drugs that are most likely to be up for negotiation. The report also details Pharma’s efforts to derail the implementation of this critical part of the Inflation Reduction Act. Prescription drug affordability measures are particularly important for seniors of color and people with disabilities, who experience health disparities in part because they are more likely to have limited access to affordable drugs. 

This event comes as Republicans and big drug companies are attacking the Inflation Reduction Act in Congress and the courts. Pharmaceutical giants Merck and Bristol Myers Squibb, as well as the industry’s trade association PhRMA, are laser-focused on undermining the Inflation Reduction Act by filing lawsuits to protect their profits and stop the administration from negotiating lower drug prices. Big Pharma’s GOP allies in Congress have already introduced legislation to repeal the Inflation Reduction Act’s prescription drug provisions, which would increase drug costs for millions of seniors.

PRESS EVENT:

WHO: U.S. Representative Gwen Moore (D-WI-4)
Wisconsin Senior Storytellers
Protect Our Care Wisconsin

WHAT: Virtual Press Conference

WHERE: Register to join the Zoom event (Registration required)

WHEN: Friday, July 7th at 11:00 AM CT // 12:00 PM ET

President Biden Reaffirms Commitment to Lower Health Care Costs for the American People

Washington, DC — Today, the Biden administration announced important new executive actions to lower health care costs and protect people with pre-existing conditions. In a speech later today, President Biden is expected to highlight new actions to eliminate surprise medical bills and limit junk insurance plans that do not need to cover people with pre-existing conditions like asthma, cancer, and diabetes. He will also give an update on the administration’s existing work to lower prescription drug costs after  HHS released a new report showing that nearly 19 million people with Medicare will save an average of $400 thanks to the Inflation Reduction Act’s $2,000 annual cost caps alone. In response, Protect Our Care Chair Leslie Dach issued the following statement: 

“President Biden is committed to lowering health care costs for the American people and protecting millions with pre-existing conditions. By signing the Inflation Reduction Act into law, President Biden finally lowered prescription drug costs after a decades-long battle with Big Pharma and their Republican allies. As we speak, the administration is working tirelessly to implement a core provision of the Inflation Reduction Act giving Medicare the power to negotiate lower prices for some of the most expensive and popular medications on the market. Combined with these efforts to eliminate surprise medical bills and limit junk plans, millions of people will see better health care thanks to President Biden.

“The contrast between President Biden’s record and the Republican war on health care could not be clearer. Republicans are siding with big drug companies to take away Medicare’s power to negotiate lower prices, and they have pledged to do everything in their power to protect drug companies’ outrageous profits at the expense of patients. Republicans in the House have also passed bills to gut protections for pre-existing conditions and take Medicaid away from millions. Unfortunately, the Republican war on health care is back with a vengeance.”

Background:

President Biden Health Care Accomplishments Tracker